Dr. Martens (LON:DOCS) Trading Down 9.6% – Time to Sell?

Shares of Dr. Martens plc (LON:DOCS) were down 9.6% during mid-day trading on Thursday . The stock traded as low as GBX 72.30 and last traded at GBX 73.80. Approximately 4,733,644 shares changed hands during trading, an increase of 115% from the average daily volume of 2,203,986 shares. The stock had previously closed at GBX 81.60.

Wall Street Analyst Weigh In

Separately, Peel Hunt reissued a “buy” rating on shares of Dr. Martens in a report on Thursday. One analyst has rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Dr. Martens currently has a consensus rating of “Hold” and an average price target of GBX 6,000.

Dr. Martens Stock Performance

The stock has a market cap of £713.15 million, a PE ratio of 147.60, a P/E/G ratio of 6.40 and a beta of 0.11. The company has a fifty day moving average price of GBX 90.30 and a 200 day moving average price of GBX 80.31. The company has a quick ratio of 1.13, a current ratio of 2.85 and a debt-to-equity ratio of 127.27.

Dr. Martens (LON:DOCS) last issued its quarterly earnings data on Thursday, November 20th. The company reported GBX (0.90) earnings per share (EPS) for the quarter. Dr. Martens had a net margin of 7.89% and a return on equity of 18.91%. Analysts expect that Dr. Martens plc will post 2.5809394 earnings per share for the current year.

Insider Buying and Selling

In other Dr. Martens news, insider Ije Nwokori sold 298,675 shares of Dr. Martens stock in a transaction on Wednesday, October 15th. The stock was sold at an average price of GBX 90, for a total value of £268,807.50. Also, insider Giles Wilson sold 30,000 shares of the firm’s stock in a transaction that occurred on Monday, September 1st. The stock was sold at an average price of GBX 91, for a total transaction of £27,300. In the last quarter, insiders have bought 136,960 shares of company stock worth $12,460,163 and have sold 434,460 shares worth $39,131,400. Corporate insiders own 2.80% of the company’s stock.

Dr. Martens Company Profile

Founded in 1960, Dr. Martens is an iconic British brand with a global presence. “Docs” or “DMs” were originally
produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical
movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history.